FEDERATED HERMES, INC. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$660,225
-34.2%
18,473
-30.5%
0.00%
-33.3%
Q4 2022$1,003,889
-13.2%
26,579
+1.7%
0.00%0.0%
Q3 2022$1,156,000
+14.6%
26,127
-4.1%
0.00%0.0%
Q2 2022$1,009,000
+48.4%
27,237
+48.3%
0.00%
+50.0%
Q1 2022$680,000
+427.1%
18,362
+331.7%
0.00%
Q4 2021$129,000
-9.8%
4,2530.0%0.00%
Q3 2021$143,000
-12.3%
4,253
+4.0%
0.00%
Q2 2021$163,000
-62.2%
4,090
-46.3%
0.00%
-100.0%
Q4 2020$431,000
+19.4%
7,622
+0.2%
0.00%0.0%
Q3 2020$361,000
-22.0%
7,604
-3.2%
0.00%0.0%
Q2 2020$463,000
-83.2%
7,856
-86.5%
0.00%
-87.5%
Q1 2020$2,753,000
+405.1%
58,235
+545.8%
0.01%
+700.0%
Q4 2019$545,000
+429.1%
9,018
+424.6%
0.00%
Q3 2019$103,000
-98.8%
1,719
-98.7%
0.00%
-100.0%
Q2 2019$8,408,000
-61.3%
130,823
-51.2%
0.02%
-63.0%
Q1 2019$21,744,000
+198.6%
267,878
+98.9%
0.05%
+170.0%
Q4 2018$7,282,000
+710.0%
134,700
+662.6%
0.02%
+566.7%
Q2 2017$899,000
-64.1%
17,664
-71.7%
0.00%
-57.1%
Q1 2017$2,507,000
+162.0%
62,358
+211.8%
0.01%
+133.3%
Q4 2016$957,000
+30.6%
20,0000.0%0.00%
+50.0%
Q3 2016$733,000
+65.8%
20,000
+5.5%
0.00%
+100.0%
Q2 2016$442,000
+44100.0%
18,966
+379220.0%
0.00%
Q4 2015$1,00050.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders